London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Doesnt read that way in the news article and yet another red day on news anyway. I wonder what is needed to get it going up lol
Kingsley Capital Partners LLP has sold 39,464,286 shares in the Company to Shareholders of Kingsley and has transferred 15,400,000 shares in the Company to employees of Kingsley.
Important this. It enables a number of investors who have long been part of the OCT story to be able to express their support for the business as individual shareholders. It clearly is a sign of growing confidence in OCT that investors want personally to become a part of the journey following last week’s Phase I announcement. Kingsley continues to be the largest shareholder in OCT.
Neil Mahapatra, Non-Executive Director of OCT and Managing Partner of Kingsley Capital Partners LLP, said:
“I am excited to be buying more into OCT personally. Given the recent Phase I results, the Company appears to me to be significantly undervalued. It is for this reason that I, along with other shareholders and employees of Kingsley, have chosen to increase our direct holding in the business.”
Our the dead donkey bully steve
I bet you loss half your money by now.
Delisted Delisted.
Repeat post bully steve
Just getting over covid and have had some what appeared to be trigemenal pain which can be a viral symptom. Was awful and not touched by available analgesics. Having read more about trigemenal Neuralgia and the limited available treatment for this miserable condition hopefully if successful our medication can’t come soon enough.
Hopefully we see more news in the media now, in the next couple of weeks.
Slowly start building upward.
There will be a fundraiser possible early next year.
What the bod should be doing, is looking for strategic investment like HEMO has done.
Can't believe we are valued less despite passing phase 1 with flying colours...we were over 1.3 not long ago.
Here's hoping!
GREAT NEWS...Clarissa said that phase 2 will take place very quickly after phase 1 in a recent interview. So far so good here...
13% up on goggle.
It's about time they give us some News.
Yes very disappointing, we need an update especially being told phase 1 last patient was administered and with all other no real adverse side effect. Come on Clarissa we are so far from the IPO at 5p now look at share holders value !!!
Give us an update which the market can relate to some positively good news
it's a dog **** company, that needs more money to fund their lifestyles.
best wait to average down again !! until they do the offering because it will have to be at a hugely discounted price than the sp to entice retailers to buy . there is a reason why they're is only 0.52% owned by institutions.
I expect positive news for phase 1 and moving quickly to phase 2. We are fully funded till April 2024.
I would expect funding via existing share holders at a much higher price than currently, with an offer of additional shares to only existing holders and the remainder a placing. OCTP will gather momentum with positive news pushing the current sp much higher before any form of fund raise in Q1 2024. Don't rule out any significant news would be an opportunity for a JV without any further funding.
What do you think the chances are if getting government funding through dr Farquhar-smith ? 🤔
OCT is now poised to publish the results of its study in the coming weeks (October 16) as it gears up to raise more funds to keep its pipeline of products moving forward.
Think this is the reason for the current price...Big issue is what they fix the fund raise price.I suspect lower than where
we are now....Just a feeling...Hope its north of 1p
If it keeps falling like this I might have to join the World hunger myself soon ......
OCTP could find a cure for cancer, HIV and dementia; invent a 100% efficient and clean power source; create a self propagating and flood, drought and disease resistant crop that could end world hunger...
...and their share price would still fall on the news.
Just had we had some good news, the bad news comes with a big seller.
I don't know what it is with these 10% sellers.
Well hello again Troajan, hopefully this fares better than the luck we're having over on BMN.
Phase 1 clinical trial with, no drug adverse effects observed
Good news.
Https://www.londonstockexchange.com/news-article/OCTP/final-dose-administered/16137098
Only 5 to wake up to disappointment then haha